496 results on '"Palesch, Yuko Y."'
Search Results
2. Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial
3. Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA
4. Prehospital Intubation is Associated with Favorable Outcomes and Lower Mortality in ProTECT III
5. Stroke Recovery and Rehabilitation Research: Issues, Opportunities, and the National Institutes of Health StrokeNet.
6. Effect of endovascular reperfusion in relation to site of arterial occlusion
7. Imaging in StrokeNet: Realizing the Potential of Big Data.
8. Blood pressure control and clinical outcomes in acute intracerebral haemorrhage: a preplanned pooled analysis of individual participant data
9. Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial
10. Very early administration of progesterone for acute traumatic brain injury.
11. Recanalization and Clinical Outcome of Occlusion Sites at Baseline CT Angiography in the Interventional Management of Stroke III Trial
12. Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial
13. Collaterals at Angiography and Outcomes in the Interventional Management of Stroke (IMS) III Trial
14. Futility Designs
15. Cigarette Smoking as a Risk Factor for Hematoma Expansion in Primary Intracerebral Hemorrhage: Analysis From a Randomized Clinical Trial
16. Sex Differences in Blood Pressure–Lowering Therapy and Outcomes Following Intracerebral Hemorrhage: Results From ATACH-2
17. National Institutes of Health Stroke Scale: An Alternative Primary Outcome Measure for Trials of Acute Treatment for Ischemic Stroke
18. Time Course for Benefit and Risk of Clopidogrel and Aspirin After Acute Transient Ischemic Attack and Minor Ischemic Stroke: A Secondary Analysis from the POINT Randomized Trial
19. Continuous covariate imbalance and conditional power for clinical trial interim analyses
20. Biostatistical Issues in TBI Clinical Trials
21. List of Contributors
22. Blood Pressure-Attained Analysis of ATACH 2 Trial
23. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging
24. High-dose albumin treatment for acute ischaemic stroke (ALIAS) part 2: a randomised, double-blind, phase 3, placebo-controlled trial
25. Multi-modality Neuro-Monitoring: Conventional Clinical Trial Design
26. Subject-investigator reproducibility of the Unified Parkinson’s Disease Rating Scale
27. Statistical Models for Quality of Life Measures
28. sj-pdf-1-wso-10.1177_17474930211064076 ��� Supplemental material for J-shape relation of blood pressure reduction and outcome in acute intracerebral hemorrhage: A pooled analysis of INTERACT2 and ATACH-II individual participant data
29. sj-pdf-1-wso-10.1177_17474930211044635 - Supplemental material for Intensive blood pressure lowering with nicardipine and outcomes after intracerebral hemorrhage: An individual participant data systematic review
30. Power of an Adaptive Trial Design for Endovascular Stroke Studies: Simulations Using IMS (Interventional Management of Stroke) III Data
31. Increased Brain Volume Among Good Grade Patients with Intracerebral Hemorrhage. Results from the Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) Study
32. ALIAS (Albumin in Acute Ischemic Stroke) Trials: Analysis of the Combined Data From Parts 1 and 2
33. Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
34. The National Institutes of Health StrokeNet: A User’s Guide
35. J-shape relation of blood pressure reduction and outcome in acute intracerebral hemorrhage: A pooled analysis of INTERACT2 and ATACH-II individual participant data
36. Endovascular Therapy Is Effective and Safe for Patients With Severe Ischemic Stroke: Pooled Analysis of Interventional Management of Stroke III and Multicenter Randomized Clinical Trial of Endovascular Therapy for Acute Ischemic Stroke in the Netherlands Data
37. Endovascular revascularization results in IMS III: intracranial ICA and M1 occlusions
38. Twelve-Month Clinical and Quality-of-Life Outcomes in the Interventional Management of Stroke III Trial
39. Intravenous nicardipine for Japanese patients with acute intracerebral hemorrhage: an individual participant data analysis.
40. High Dose Deferoxamine in Intracerebral Hemorrhage (Hi-Def) Trial: Rationale, Design, and Methods
41. Association of Serum Glucose Concentrations During Acute Hospitalization with Hematoma Expansion, Perihematomal Edema, and Three Month Outcome Among Patients with Intracerebral Hemorrhage
42. Some Common Misperceptions About P Values
43. Evolution of Practice During the Interventional Management of Stroke III Trial and Implications for Ongoing Trials
44. Drivers of Costs Associated With Reperfusion Therapy in Acute Stroke: The Interventional Management of Stroke III Trial
45. Challenges of Decision Making Regarding Futility in a Randomized Trial: The Interventional Management of Stroke III Experience
46. Alberta Stroke Program Early Computed Tomography Score to Select Patients for Endovascular Treatment: Interventional Management of Stroke (IMS)-III Trial
47. Abstracts from ASENT 2004 Annual Meeting March 11–13, 2004
48. Acute Ischemic Stroke
49. Computed tomographic colonography (virtual colonoscopy)
50. Endovascular Treatment for Acute Ischemic Stroke
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.